Although the positive correlation between TAP1 and CXCL13 was weak in ovarian cancers according to the cBioPortal database, some studies still screened that they can be both used as prognostic markers of ovarian cancer (Liu et al., 2020; Wu et al., 2020). Here, TAP1 is linked to ovarian carcinoma.